No Toxicity Hit With Avastin in Glioblastoma (CME/CE)

ATLANTA (MedPage Today) -- Progression of glioblastoma slowed significantly without added toxicity when patients received bevacizumab with standard chemoradiation, results of a randomized trial showed.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news